心肺运动测试 (CPET) 市场规模、份额和成长分析：按产品、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年心肺运动测试（CPET）市场规模为35.3亿美元，从2023年的37亿美元成长到2031年的37亿美元，预测增长期内（2024-2031年）复合年增长率为4.7%。至73 亿美元。

心血管疾病对全球医疗保健产业来说是一个重大且不断升级的挑战，需要紧急关注和有效的诊断方法。一个引人注目的例子是欧洲心臟网路2021年发布的资料，凸显了心血管疾病对整个欧盟（EU）的严重影响。研究发现，该地区有超过6,000万人患有心血管疾病，每年新诊断病例近1,300万例。这种高盛行率凸显了对预防措施的迫切需要，包括广泛采用压力测试方法，以实现心臟病的早期发现和介入。心血管疾病的负担日益加重，给全世界的卫生系统带来了巨大的压力，这凸显了需要采取全面的策略和先进的诊断工具来应对这一日益严重的公共卫生挑战。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 关键成功因素
• 市场吸引力指数
• 竞争程度
• 主要投资机会
• 生态系绘图

心肺运动测试 (CPET) 市场：按产品

• 市场概况
• 单光子发射断层扫描 (SPECT)
• 心肺运动测试（CPET）系统
• 心臟超音波图
• 脉动式血氧监测仪系统
• 压力血压计
• 其他的

心肺运动测试（CPET）市场：依应用分类

• 市场概况
• 氧气摄入量
• 二氧化碳
• 分钟通气量
• 无氧代谢阈值（AT）

心肺运动测试 (CPET) 市场：按最终用户分类

• 市场概况
• 诊断中心
• 门诊中心
• 诊所/医院
• 其他的

按地区分類的心肺运动测试 (CPET) 市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• COSMED SRL（Italy）
• Vyaire Medical Inc.（USA）
• MGC Diagnostics Corporation（USA）
• Hill-Rom Holdings Inc.（USA）
• GE Healthcare（USA）
• Koninklijke Philips NV（Netherlands）
• Nihon Kohden Corporation（Japan）
• Schiller AG（Switzerland）
• Masimo Corporation（USA）
• Cardinal Health（USA）
• CareFusion Corporation（USA）
• SunTech Medical, Inc.（USA）
• Geratherm Medical AG（Germany）
• Spacelabs Healthcare（USA）
• Welch Allyn（USA）
• Microlife Medical Home Solutions Inc.（Switzerland）
• Medisoft SA（Belgium）
• CAIRE Inc.（USA）
• Becton, Dickinson and Company（USA）

Cardiopulmonary Exercise Testing Market size was valued at USD 3.53 billion in 2022 and is poised to grow from USD 3.70 billion in 2023 to USD 7.3 billion by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).

Cardiovascular diseases pose a significant and escalating challenge for the global healthcare sector, demanding urgent attention and effective diagnostic approaches. A striking example is data published by the European Heart Network in 2021, highlighting the profound impact of cardiovascular diseases across the European Union. According to the report, more than 60 million individuals in the region live with cardiovascular disease, with nearly 13 million new cases diagnosed annually. This high prevalence underscores the critical necessity for proactive measures, including widespread adoption of stress testing procedures, to enable early detection and intervention in heart diseases. The growing burden of cardiovascular conditions places substantial pressure on healthcare systems worldwide, underscoring the need for comprehensive strategies and advanced diagnostic tools to address this escalating public health challenge.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiopulmonary Exercise Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiopulmonary Exercise Testing Market Segmental Analysis

The cardiopulmonary exercise testing market is segmented into product, application, end user, and region. Based on product, the cardiopulmonary exercise testing market is segmented into single-photon emission computed tomography, cardiopulmonary exercise testing systems, echocardiogram, pulse oximeters, stress blood pressure monitors and others. Based on application, the market is segmented into oxygen uptake, carbon dioxide, minute ventilation, and anaerobic threshold. Based on end-user, the cardiopulmonary exercise testing market is segmented into diagnostic centers, ambulatory centers, clinics and hospitals and others. Based on region, the cardiopulmonary exercise testing market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Cardiopulmonary Exercise Testing Market

The integration of cardiopulmonary exercise testing (CPET) with telemedicine platforms and simple wearable devices represents a transformative advancement in healthcare. This integration empowers individuals through remote monitoring and enables home-based research. Telemedicine platforms allow patients to undergo CPET from the convenience of their homes, overcoming geographical constraints and broadening access to essential health services. The inclusion of wearable devices enhances this approach further, as they enable individuals to capture real-time data and transmit it to healthcare providers. This plays a crucial role in preventive healthcare, early detection, and continuous management of cardiopulmonary conditions.

Restraints in the Cardiopulmonary Exercise Testing Market

The growth of the cardiopulmonary exercise testing market faces challenges due to the considerable costs involved in these diagnostic procedures. The high expenses associated with acquiring, installing, and maintaining cardiopulmonary exercise testing equipment serve as a substantial barrier to market expansion. This financial hurdle could restrict access to these testing methods for healthcare providers and patients alike, thereby potentially slowing down the adoption of cardiopulmonary exercise testing on a broader scale. Economic factors related to these tests may present difficulties for healthcare facilities, especially in areas with limited healthcare budgets.

Market Trends of the Cardiopulmonary Exercise Testing Market

The cardiopulmonary exercise testing market is set to expand, driven by a variety of exercise testing systems offered by major industry players, each offering numerous benefits and continuous advancements. A notable example occurred in May 2022, when MGC Diagnostics, a leading global medical technology company, announced a strategic collaboration with UK-based med-tech firm Bedfont Scientific Ltd. Known for its expertise in breath analysis, Bedfont Scientific has developed the NObreath fractional exhaled nitric oxide test monitor, suitable for both hospital and remote settings. Such collaborative ventures and partnerships among key industry leaders are expected to significantly contribute to the growth of the cardiopulmonary exercise testing market. These initiatives underscore a commitment to introducing cutting-edge technologies and solutions, driving expansion in this sector over the forecast period.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Cardiopulmonary Exercise Testing Market by Product

• Market Overview
• Single-photon Emission Computed Tomography
• Cardiopulmonary Exercise Testing Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

Cardiopulmonary Exercise Testing Market by Application

• Market Overview
• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

Cardiopulmonary Exercise Testing Market by End User

• Market Overview
• Diagnostic Centers
• Ambulatory Centers
• Clinics & Hospitals
• Others

Cardiopulmonary Exercise Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• COSMED SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGC Diagnostics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hill-Rom Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareFusion Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SunTech Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geratherm Medical AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spacelabs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welch Allyn (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Medical Home Solutions Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisoft SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAIRE Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments